Data as of Jul 29
| +0.56 / +4.28%|
The 9 analysts offering 12-month price forecasts for Celldex Therapeutics Inc have a median target of 35.00, with a high estimate of 45.00 and a low estimate of 30.00. The median estimate represents a +156.41% increase from the last price of 13.65.
The current consensus among 9 polled investment analysts is to Buy stock in Celldex Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.